Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
VALUE IN HEALTH
Journal
Overview
Research
Identity
Other
View All
Overview
publication venue for
SIMULATED MOS OF GEMCITABINE plus CARBOPLATIN +/- MAINTENANCE AVELUMAB THERAPY OR ENFORTUMAB VEDOTIN plus PEMBROLIZUMAB IN FIRST-LINE TREATMENT OF LA/MUC IN PATIENTS INELIGIBLE FOR CISPLATIN USING DISEASE MODELING
2023
SIMULATING THE IMPACT OF FIRST-LINE TREATMENT CHOICE ON SURVIVAL AMONG PATIENTS WITH LOCALLY ADVANCED/METASTATIC UROTHELIAL CARCINOMA CONSIDERED CISPLATIN INELIGIBLE
2023
VALUE AS THE NEXT INNOVATION IN RECTAL CANCER SURGERY: A REVIEW
2023
PATIENT-CENTERED OUTCOMES IN ARIEL3, A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH RECURRENT OVARIAN CARCINOMA
2019
Research
category
ECONOMICS
Web of Science Category
HEALTH CARE SCIENCES & SERVICES
Web of Science Category
HEALTH POLICY & SERVICES
Web of Science Category
Identity
International Standard Serial Number (ISSN)
1098-3015
Electronic International Standard Serial Number (EISSN)
1524-4733
Other
journal abbreviation
VALUE HEALTH